U.K. Pharmaceuticals & Biotech High Insider Buying

Haleon

Market Cap: UK£31.6b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Hikma Pharmaceuticals

Market Cap: UK£3.1b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

Genus

Market Cap: UK£1.4b

Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.

Oxford Nanopore Technologies

Market Cap: UK£1.1b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.

PureTech Health

Market Cap: UK£302.3m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Animalcare Group

Market Cap: UK£230.3m

Develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.

Bioventix

Market Cap: UK£82.3m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

OptiBiotix Health

Market Cap: UK£6.6m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.

Physiomics

Market Cap: UK£2.5m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.